Intra-Cellular Therapies Inc. buy Needham & Company LLC
Start price
22.04.24
/
50%
€70.50
Target price
22.04.25
€84.46
Performance (%)
-7.09%
Price
15:56
€65.50
Summary
This prediction is currently active. With a performance of -7.09%, the BUY prediction for Intra-Cellular Therapies Inc. by Needham___Company_LL is down slightly. This prediction currently runs until 22.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intra-Cellular Therapies Inc. | -2.222% |
| iShares Core DAX® | 0.000% |
| iShares Nasdaq 100 | 0.626% |
| iShares Nikkei 225® | 1.568% |
| iShares S&P 500 | 0.334% |
Comments by Needham___Company_LL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Needham & Company LLC from $82.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Needham___Company_LL for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
05.04.24
05.04.24
€75.83
05.04.25
05.04.25
2.34%
15:56
15:56
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
23.02.24
23.02.24
€75.68
23.02.25
23.02.25
3.15%
15:56
15:56
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.70
03.08.23
03.08.23
€66.63
03.08.24
03.08.24
25.70%
15:56
15:56
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€56.40
20.04.23
20.04.23
€60.11
20.04.24
20.04.24
22.34%
21.04.24
21.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€60.85
29.03.24
29.03.24
22.14%
30.03.24
30.03.24